NUS

Nu Skin Enterprises Inc. (NUS) | Rumor.io

Nu Skin Enterprises

NUS

Attention (50-day avg)0%

Attention rank (50-day avg)#3,908

Bullish sentiment (50-day avg)20%

Price to earnings ratio4.77

Market capitalization225.9M

Earnings per share-4.53

Dividend yield (TTM)5.17%

Revenue (annual)1.5B

Net income (annual)160.2M

Social

What share of all stock conversation is about NUS?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% +0	0% 0	0% 0

Aug 10

Nu Skin Enterprises reported a massive impairment and slashed guidance, exposing flaws in its turnaround strategy, with Adjusted EPS meeting expectations but GAAP Net Income collapsing to a $249.8 million loss.
The company's Q2 2026 earnings results were disappointing, with reported revenue of $320.1M, down 17% YoY, and GAAP EPS of -$5.14, a -1295.35% YoY decline.
Nu Skin's management has been criticized, with the CEO, Ryan Napierski, facing accusations of corporate fraud and the company's sales leaders leaving, while investors are exiting the stock, which has been described as a penny stock in the making.

Generated by AI

Sentiment

Of the messages about NUS that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	17.39% -64.11
Bearish	—	—	—	82.61% +64.11

Bullish· Jan 3

$NUS is undervalued based on its book value, potentially leading to a double in value.
The company's strategic transaction of Mavely for $250 million, a 5x return on investment since 2021, is a significant positive development.
The recent premarket action, including a 14.3% increase and a share buyback program, indicates solid momentum and a potential run-up in the stock.

Bearish· Feb 15

Nu Skin Enterprises, Inc. reported disappointing earnings, with shares trading 25% lower in pre-market action and down -20.71%.
The company's Q4 earnings beat estimates but provided disappointing 2024 guidance, and it cut its dividend from $0.39 to $0.06 per share.
Nu Skin's business model has been described as a "multi-level ponzi scam" with declining demand and a history of disappointing earnings, leading to a significant decline in stock value.

Generated by AI

Topics

Of the messages about NUS that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	—	100%	100%	45%
Earnings	—	0%	0%	16.67%
Technical Analysis	—	0%	0%	16.67%
Analysts	—	0%	0%	0%
Controversies	—	0%	0%	1.67%
Macro	—	0%	0%	20%

Earnings· Feb 16

Nu Skin Enterprises reported Q4 earnings of $1.11, beating consensus of $0.95.
The company guided Q1 EPS to $0.65-$0.75, below consensus, and revenue to $560-$590 million, also below consensus.
Nu Skin Enterprises updated FY22 guidance to $4.05-$4.45 EPS and revenue to $2.66-$2.77 billion.

Analysts· Oct 2

Nu Skin Enterprises ($NUS) has been upgraded to Neutral by Bank of America, with a price target of $58.
DA Davidson has maintained a Buy rating on $NUS with a price target of $68.00.
Jefferies Financial Group analysts have increased earnings estimates for Nu Skin Enterprises ($NUS) and raised the price target to $60.00.

Announcements· Jan 3

Nu Skin Enterprises (NUS) announced a strategic transaction of its Mavely affiliate marketing technology platform for $250 million in a mixed cash and equity deal.
The transaction is expected to generate a 5x return on investment since the 2021 acquisition, with funds to be used to pay debts and repurchase shares.
NUS shares rose 14.3% premarket to $7.60, with the company also announcing a planned share buyback program to enhance shareholder value.

Controversies· Mar 24

Nu Skin Enterprises ($NUS) was fined $540,000 by Chinese regulators for illegal sales and product claims.
The fine had a positive impact on the company's stock price, with shares surging 25% in pre-market trading.
Analysts have downplayed the severity of the fine, with Wedbush stating that it was "nothing more than a slap on the wrist" and maintaining an Outperform rating for the company.

Macro· Mar 14

Economists do not see a catalyst for a super cycle in the global economy, but a swift expansion is expected to power demand.
Oil consumption is expected to slow down, which may impact the commodity market.
A super cycle is unlikely due to the lack of a similar catalyst, according to analysts.

Technical Analysis· Jan 16

$NUS may experience a bounce after a strong defense by the company, but some consider it too early to buy.
A possible short position could be taken on an intraday bounce, but there's a high risk of a "dead cat bounce".
$NUS is finding support at the 200-day MA, and some traders are watching for a potential double bottom around 70.

Generated by AI

Community

Of the messages about NUS, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	10%	21.43%	8.02%
Newcomers	—	90%	78.57%	91.98%

Regulars· Feb 15

Nu Skin Enterprises, Inc. (NUS) cut its dividend by 85% and guided for first-quarter revenue of $400M to $435M, below consensus estimates.
The stock is down over 20% after the dividend cut and guidance miss, on pace for its largest percent decrease since October 2015.
Regulars are focused on the company's troubled and outdated business model, with some comparing it to Herbalife and others noting the sharp decline in revenue and profits in Q4 2023.

Newcomers· Feb 14

Nu Skin's Q4 revenue and EPS surprised investors, with revenue at $445.6M and EPS at $0.38, a 72.3% increase from expectations.
The company's Q1 revenue guidance missed estimates, and the 2025 revenue outlook was also below expectations, sparking concerns about the future.
The stock's price surge after the earnings release was short-lived, with the stock down 12.08% at $8.59 in the last 20 minutes.

Generated by AI

News

Nu Skin: The Turnaround Is Behind Before It's Started (NYSE:NUS)

23h agoSeeking Alpha

Nu Skin Ranked the World's #1 Company for Beauty and Wellness Device Systems for Third Consecutive Year

26d agoFinancial Times

Nu Skin Ranked the World’s #1 Company for Beauty and Wellness Device Systems for Third Consecutive Year

PROVO, Utah, September 03, 2026--Nu Skin Enterprises Inc. (NYSE: NUS), a global beauty and wellness leader, has been ranked the world’s No. 1 company for beauty and wellness device systems by Euromonitor International Ltd. for the third consecutive year.*

26d agoYahoo Finance

Stonegate Capital Partners Updates Coverage on NU Skin Enterprises Inc. (NUS) 2Q26

Dallas, Texas--(Newsfile Corp. - August 11, 2026) - NU Skin Enterprises Inc. (NYSE: NUS): Stonegate Capital Partners updates their coverage on NU Skin Enterprises Inc. (NYSE: NUS). NUS reported revenue, adj NI, and adj EPS of $320.1M, $10.0M, and $0.20, respectively. This compares to our estimates of $345.2M, $10.3M, and $0.20, respectively. GAAP EPS was $(5.14), primarily reflecting a $78.9M non-cash goodwill impairment, which was largely a GAAP accounting item, and a $167.5M...

1mo agofinance.yahoo.com

Nu Skin Enterprises Q2 Earnings Meet Estimates, Revenues Down Y/Y

NUS' second-quarter revenues fall 17.1% and EPS drops 53.5%, while it cuts the 2026 revenue and adjusted EPS outlooks.

1mo agoYahoo! Finance Canada

Nu Skin Enterprises Q2 Earnings Call Highlights

Nu Skin Enterprises (NYSE:NUS) reported second-quarter revenue of $320.1 million and adjusted earnings per share of $0.20, as the company continued the rollout of its Prysm iO wellness platform and pursued cost and margin initiatives. Reported earnings per share were negative $5.14 for the quarter,

1mo agoYahoo Finance

Also Discussed

Investors talking about NUS also mention

#	Name	Attention
1	Usana Health Sciences, Inc.USNA	0%new
2	Herbalife Ltd.HLF	0%new
3	LL - LL Flooring Holdings, Inc.	——
4	Jazz Pharmaceuticals plcJAZZ	0%0
5	CONN - Conn's, Inc.	——
6	Sohu.com Limited Sponsored ADRSOHU	0%new
7	Yelp Inc.YELP	0%-0.01
8	VJET - voxeljet AG	——
9	Proto Labs, Inc.PRLB	0%new
10	JOYY Inc. American Depositary SharesYY	0%0

Nu Skin Enterprises Inc.

Consumer Defensive
Household & Personal Products

Nu Skin Enterprises Inc. is a global direct selling company specializing in the marketing and distribution of premium-quality personal care products and dietary supplements. The company's primary purpose is to empower individuals by providing them with the opportunity to run personal businesses by selling its diverse array of beauty and wellness products. Notably, it operates in sectors like skincare, health and nutrition, aiming to promote healthier lifestyles and aging solutions. Nu Skin leverages a unique business model, combining innovative product development with a robust, entrepreneur-focused sales strategy. This model not only impacts individuals at the grassroots level by fostering entrepreneurial initiatives but also significantly influences the larger market trends in nutraceuticals and personal care. Established in 1984 and headquartered in Provo, Utah, Nu Skin has expanded its reach globally, with operations in multiple international markets. It is recognized for its commitment to quality and sustainability, integrating cutting-edge scientific research into its product offerings while maintaining a strong presence in the competitive direct selling industry.

Website

Location

75 West Center Street

Provo, UT, 84601

United States

Social

What share of all stock conversation is about NUS?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% +0	0% 0	0% 0

Aug 10

Nu Skin Enterprises reported a massive impairment and slashed guidance, exposing flaws in its turnaround strategy, with Adjusted EPS meeting expectations but GAAP Net Income collapsing to a $249.8 million loss.
The company's Q2 2026 earnings results were disappointing, with reported revenue of $320.1M, down 17% YoY, and GAAP EPS of -$5.14, a -1295.35% YoY decline.
Nu Skin's management has been criticized, with the CEO, Ryan Napierski, facing accusations of corporate fraud and the company's sales leaders leaving, while investors are exiting the stock, which has been described as a penny stock in the making.

Generated by AI

Sentiment

Of the messages about NUS that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	17.39% -64.11
Bearish	—	—	—	82.61% +64.11

Bullish· Jan 3

$NUS is undervalued based on its book value, potentially leading to a double in value.
The company's strategic transaction of Mavely for $250 million, a 5x return on investment since 2021, is a significant positive development.
The recent premarket action, including a 14.3% increase and a share buyback program, indicates solid momentum and a potential run-up in the stock.

Bearish· Feb 15

Nu Skin Enterprises, Inc. reported disappointing earnings, with shares trading 25% lower in pre-market action and down -20.71%.
The company's Q4 earnings beat estimates but provided disappointing 2024 guidance, and it cut its dividend from $0.39 to $0.06 per share.
Nu Skin's business model has been described as a "multi-level ponzi scam" with declining demand and a history of disappointing earnings, leading to a significant decline in stock value.

Generated by AI

Topics

Of the messages about NUS that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	—	100%	100%	45%
Earnings	—	0%	0%	16.67%
Technical Analysis	—	0%	0%	16.67%
Analysts	—	0%	0%	0%
Controversies	—	0%	0%	1.67%
Macro	—	0%	0%	20%

Earnings· Feb 16

Nu Skin Enterprises reported Q4 earnings of $1.11, beating consensus of $0.95.
The company guided Q1 EPS to $0.65-$0.75, below consensus, and revenue to $560-$590 million, also below consensus.
Nu Skin Enterprises updated FY22 guidance to $4.05-$4.45 EPS and revenue to $2.66-$2.77 billion.

Analysts· Oct 2

Nu Skin Enterprises ($NUS) has been upgraded to Neutral by Bank of America, with a price target of $58.
DA Davidson has maintained a Buy rating on $NUS with a price target of $68.00.
Jefferies Financial Group analysts have increased earnings estimates for Nu Skin Enterprises ($NUS) and raised the price target to $60.00.

Announcements· Jan 3

Nu Skin Enterprises (NUS) announced a strategic transaction of its Mavely affiliate marketing technology platform for $250 million in a mixed cash and equity deal.
The transaction is expected to generate a 5x return on investment since the 2021 acquisition, with funds to be used to pay debts and repurchase shares.
NUS shares rose 14.3% premarket to $7.60, with the company also announcing a planned share buyback program to enhance shareholder value.

Controversies· Mar 24

Nu Skin Enterprises ($NUS) was fined $540,000 by Chinese regulators for illegal sales and product claims.
The fine had a positive impact on the company's stock price, with shares surging 25% in pre-market trading.
Analysts have downplayed the severity of the fine, with Wedbush stating that it was "nothing more than a slap on the wrist" and maintaining an Outperform rating for the company.

Macro· Mar 14

Economists do not see a catalyst for a super cycle in the global economy, but a swift expansion is expected to power demand.
Oil consumption is expected to slow down, which may impact the commodity market.
A super cycle is unlikely due to the lack of a similar catalyst, according to analysts.

Technical Analysis· Jan 16

$NUS may experience a bounce after a strong defense by the company, but some consider it too early to buy.
A possible short position could be taken on an intraday bounce, but there's a high risk of a "dead cat bounce".
$NUS is finding support at the 200-day MA, and some traders are watching for a potential double bottom around 70.

Generated by AI

Community

Of the messages about NUS, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	10%	21.43%	8.02%
Newcomers	—	90%	78.57%	91.98%

Regulars· Feb 15

Nu Skin Enterprises, Inc. (NUS) cut its dividend by 85% and guided for first-quarter revenue of $400M to $435M, below consensus estimates.
The stock is down over 20% after the dividend cut and guidance miss, on pace for its largest percent decrease since October 2015.
Regulars are focused on the company's troubled and outdated business model, with some comparing it to Herbalife and others noting the sharp decline in revenue and profits in Q4 2023.

Newcomers· Feb 14

Nu Skin's Q4 revenue and EPS surprised investors, with revenue at $445.6M and EPS at $0.38, a 72.3% increase from expectations.
The company's Q1 revenue guidance missed estimates, and the 2025 revenue outlook was also below expectations, sparking concerns about the future.
The stock's price surge after the earnings release was short-lived, with the stock down 12.08% at $8.59 in the last 20 minutes.

Generated by AI

Nu Skin Enterprises

Social

Aug 10

Bullish· Jan 3

Bearish· Feb 15

Earnings· Feb 16

Analysts· Oct 2

Announcements· Jan 3

Controversies· Mar 24

Macro· Mar 14

Technical Analysis· Jan 16

Regulars· Feb 15

Newcomers· Feb 14

Nu Skin: The Turnaround Is Behind Before It's Started (NYSE:NUS)

Nu Skin Ranked the World's #1 Company for Beauty and Wellness Device Systems for Third Consecutive Year

Nu Skin Ranked the World’s #1 Company for Beauty and Wellness Device Systems for Third Consecutive Year

Stonegate Capital Partners Updates Coverage on NU Skin Enterprises Inc. (NUS) 2Q26

Nu Skin Enterprises Q2 Earnings Meet Estimates, Revenues Down Y/Y

Nu Skin Enterprises Q2 Earnings Call Highlights

Also Discussed

Nu Skin Enterprises Inc.

Company Information

Location

Nu Skin: The Turnaround Is Behind Before It's Started (NYSE:NUS)

Nu Skin Ranked the World's #1 Company for Beauty and Wellness Device Systems for Third Consecutive Year

Nu Skin Ranked the World’s #1 Company for Beauty and Wellness Device Systems for Third Consecutive Year

Stonegate Capital Partners Updates Coverage on NU Skin Enterprises Inc. (NUS) 2Q26

Nu Skin Enterprises Q2 Earnings Meet Estimates, Revenues Down Y/Y

Nu Skin Enterprises Q2 Earnings Call Highlights

Also Discussed

Social

Aug 10

Bullish· Jan 3

Bearish· Feb 15

Earnings· Feb 16

Analysts· Oct 2

Announcements· Jan 3

Controversies· Mar 24

Macro· Mar 14

Technical Analysis· Jan 16

Regulars· Feb 15

Newcomers· Feb 14